| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |